MBL2 and Parkinson disease: In an MPTP-induced mouse model of PD, systemic injection of MSCs supported blood–brain barrier (BBB) integrity, averted mannose-binding lectin (MBL) infiltration at substantia nigra compacta (SNc), inhibited microglial function, and counteracted dopaminergic neuron loss [110].